(ARCC) Ares Capital - Overview
Sector: Financial Services | Industry: Asset Management | Exchange: NASDAQ (USA) | Market Cap: 12.530m USD | Total Return: -10.7% in 12m
Avg Trading Vol: 145M USD
Peers RS (IBD): 36.3
EPS Trend: -46.4%
Qual. Beats: 0
Rev. Trend: 73.9%
Qual. Beats: 0
Ares Capital Corporation (NASDAQ: ARCC) operates as a business-development company (BDC) that provides growth capital, acquisition financing, mezzanine debt, and restructuring solutions to middle-market U.S. companies.
The firm targets sectors such as basic and growth manufacturing, business services, consumer products, health-care, and information-technology services, while also evaluating opportunities in restaurants, retail, oil & gas, and broader technology industries across the Northeast, Mid-Atlantic, Southeast, Southwest, Midwest and Western regions.
Typical transaction sizes range from $30 million to $500 million for equity investments and $10 million to $100 million for debt, employing structures like first-lien loans, unitranche facilities, mezzanine debt, warrants and non-control equity, often with ARCC acting as lead investor and securing board representation.
As of the most recent quarter, ARCC reported $13.5 billion in assets under management, a dividend yield of roughly 9.2 %, and a net interest margin of 6.1 %, reflecting the BDC sector’s resilience amid a tightening credit environment and strong demand for middle-market financing.
For a deeper dive into ARCC’s valuation metrics and competitive positioning, consider exploring ValueRay’s analytical tools.
- Middle market lending volume impacts new investment opportunities
- Interest rate fluctuations affect net investment income
- Credit quality of portfolio companies drives loan losses
- Economic downturns increase default risk for borrowers
| Net Income: 1.30b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -0.88 > 1.0 |
| NWC/Revenue: 27.43% < 20% (prev 31.69%; Δ -4.26% < -1%) |
| CFO/TA 0.04 > 3% & CFO 1.14b > Net Income 1.30b |
| Net Debt (15.07b) to EBITDA (1.59b): 9.50 < 3 |
| Current Ratio: 1.71 > 1.5 & < 3 |
| Outstanding Shares: last quarter (699.0m) vs 12m ago 6.72% < -2% |
| Gross Margin: 68.60% > 18% (prev 0.72%; Δ 6.79k% > 0.5%) |
| Asset Turnover: 7.78% > 50% (prev 8.32%; Δ -0.54% > 0%) |
| Interest Coverage Ratio: 0.54 > 6 (EBITDA TTM 1.59b / Interest Expense TTM 645.2m) |
| A: 0.02 (Total Current Assets 1.53b - Total Current Liabilities 894.0m) / Total Assets 31.23b |
| B: 0.03 (Retained Earnings 958.0m / Total Assets 31.23b) |
| C: 0.01 (EBIT TTM 349.0m / Avg Total Assets 29.74b) |
| D: 0.06 (Book Value of Equity 959.0m / Total Liabilities 16.92b) |
| Altman-Z'' Score: 0.37 = B |
| DSRI: 1.19 (Receivables 605.0m/516.0m, Revenue 2.31b/2.35b) |
| GMI: 1.05 (GM 68.60% / 71.97%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 0.98 (Revenue 2.31b / 2.35b) |
| TATA: 0.01 (NI 1.30b - CFO 1.14b) / TA 31.23b) |
| Beneish M-Score: cannot calculate (missing components) |
Over the past week, the price has changed by +0.33%, over one month by -2.47%, over three months by -8.49% and over the past year by -10.69%.
- StrongBuy: 7
- Buy: 4
- Hold: 2
- Sell: 0
- StrongSell: 0
| ISSUER | TARGET | UP/DOWN |
|---|---|---|
| Wallstreet Target Price | 21.9 | 21.4% |
| Analysts Target Price | 21.9 | 21.4% |
P/E Forward = 9.3023
P/S = 4.1053
P/B = 0.9007
P/EG = 3.7176
Revenue TTM = 2.31b USD
EBIT TTM = 349.0m USD
EBITDA TTM = 1.59b USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 15.99b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 15.07b USD (from netDebt column, last quarter)
Enterprise Value = 27.60b USD (12.53b + Debt 15.99b - CCE 924.0m)
Interest Coverage Ratio = 0.54 (Ebit TTM 349.0m / Interest Expense TTM 645.2m)
EV/FCF = 24.17x (Enterprise Value 27.60b / FCF TTM 1.14b)
FCF Yield = 4.14% (FCF TTM 1.14b / Enterprise Value 27.60b)
FCF Margin = 49.33% (FCF TTM 1.14b / Revenue TTM 2.31b)
Net Margin = 56.11% (Net Income TTM 1.30b / Revenue TTM 2.31b)
Gross Margin = 68.60% ((Revenue TTM 2.31b - Cost of Revenue TTM 727.0m) / Revenue TTM)
Gross Margin QoQ = 70.39% (prev 70.23%)
Tobins Q-Ratio = 0.88 (Enterprise Value 27.60b / Total Assets 31.23b)
Interest Expense / Debt = 0.66% (Interest Expense 106.2m / Debt 15.99b)
Taxrate = 8.15% (26.0m / 319.0m)
NOPAT = 320.6m (EBIT 349.0m * (1 - 8.15%))
Current Ratio = 1.71 (Total Current Assets 1.53b / Total Current Liabilities 894.0m)
Debt / Equity = 1.12 (Debt 15.99b / totalStockholderEquity, last quarter 14.32b)
Debt / EBITDA = 9.50 (Net Debt 15.07b / EBITDA 1.59b)
Debt / FCF = 13.19 (Net Debt 15.07b / FCF TTM 1.14b)
Total Stockholder Equity = 14.09b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.37% (Net Income 1.30b / Total Assets 31.23b)
RoE = 9.22% (Net Income TTM 1.30b / Total Stockholder Equity 14.09b)
RoCE = 1.15% (EBIT 349.0m / Capital Employed (Total Assets 31.23b - Current Liab 894.0m))
RoIC = 1.11% (NOPAT 320.6m / Invested Capital 28.99b)
WACC = 3.95% (E(12.53b)/V(28.52b) * Re(8.21%) + D(15.99b)/V(28.52b) * Rd(0.66%) * (1-Tc(0.08)))
Discount Rate = 8.21% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 8.57%
[DCF] Terminal Value 87.37% ; FCFF base≈1.20b ; Y1≈1.34b ; Y5≈1.77b
[DCF] Fair Price = 51.55 (EV 52.08b - Net Debt 15.07b = Equity 37.01b / Shares 718.0m; r=6.0% [WACC]; 5y FCF grow 13.58% → 3.0% )
EPS Correlation: -46.35 | EPS CAGR: -44.69% | SUE: -4.0 | # QB: 0
Revenue Correlation: 73.94 | Revenue CAGR: 15.08% | SUE: 0.44 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.48 | Chg7d=-0.002 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=13
EPS current Year (2026-12-31): EPS=1.93 | Chg7d=-0.009 | Chg30d=+0.001 | Revisions Net=-2 | Growth EPS=-3.8% | Growth Revenue=+3.2%
EPS next Year (2027-12-31): EPS=1.93 | Chg7d=-0.002 | Chg30d=+0.003 | Revisions Net=-2 | Growth EPS=-0.4% | Growth Revenue=+4.3%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -2.4% (Discount Rate 8.2% - Earnings Yield 10.7%)
[Growth] Growth Spread = +7.6% (Analyst 5.2% - Implied -2.4%)